HUMAN PROSTATE CARCINOMA PROLIFERATION IN STRONGLY REDUCED BY THE EPIDERMAL GROWTH FACTOS RECEPTOR TIROSINE KINASE INHIBITOR (EGFR-TKI) ZD1839 (‘IRESSA) IN VITRO